logo

For the Inventor, By the Inventor

Wen-Hwa Lee

Newport Coast, CA, United States of America

Wen-Hwa Lee

wikipedia

This inventor holds 21 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent, primarily in Cancer Therapeutics. Top assignees: University of California, Canji Inc., The University of Texas System. Active years: 1990-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Wen-Hwa Lee. Retrieved from https://idiyas.com/inventor/wen-hwa-lee

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 21 

% Patents Active = 95.2


Average Co-Inventor Count = 2.8

ph-index = 5

Forward Citations = 93(Granted Patents)


Location History:

  • San Diego, CA (US) (1990 - 2000)
  • San Antonio, TX (US) (1998 - 2006)
  • Irvine, CA (US) (2016 - 2017)
  • Newport Coast, CA (US) (2006 - 2020)
  • Taipei, TW (2020)

Company Filing History:

goldMedal17 out of 16,025 
 
University of California
 patents
silverMedal2 out of 42 
 
Canji Inc.
 patents
bronzeMedal2 out of 5,638 
 
The University of Texas System
 patents
4. 1 out of 726 
 
Academia Sinica
 patents
5. 1 out of 8 
 
Taivex Therapeutics Corporation
 patents
where one patent can have more than one assignee

Years Active: 1990-2020

Loading Chart...
Loading Chart...
Areas of Expertise:
Rad51 Inhibitors
Cancer Therapy
Retinoblastoma
Antibodies
Proliferative Diseases
Hec1-Nek2 Interaction
Tumor Suppression
Pharmaceutical Compositions
Genetic Mechanisms
Nuclear Phosphoprotein
Indoyl Isoquinoline
Adenoviral Vector
21 patents (USPTO):Explore Patents
1. 10793628 - Isolated antibodies against interleukin-17 receptor B (IL-17RB) for cancer therapy (2020-10-06),
2. 10730864 - RAD51 inhibitors and uses thereof (2020-08-04),
3. 10421753 - RAD51 inhibitors and uses thereof (2019-09-24),
4. 9670197 - Small molecule modifiers of the Hec1-Nek2 interaction in G2/M (2017-06-06),
5. 9422275 - Small molecule modifiers of the HEC1-NEK2 interaction in G2/M (2016-08-23),
6. 9012455 - Pharmaceutical compositions containing an indoyl isoquinoline containing compound and uses thereof (2015-04-21),
7. 8293764 - Compositions and methods for disruption of BRCA2-Rad51 interaction (2012-10-23),
8. 8252520 - Methods and compounds for inhibiting Hec1 activity for the treatment of proliferative diseases (2012-08-28),
9. 7105156 - Method of using an adenoviral vector encoding a retinoblastoma protein to treat hyperproliferating cells (2006-09-12),
10. 7060688 - Products and methods for controlling the suppression of the neoplastic phenotype (2006-06-13),
11. 6133424 - ppRB.sup.110 - nuclear phosphoprotein-the retinoblastoma susceptibility (2000-10-17),
12. 6051396 - Method for producing retinoblastoma gene protein products (2000-04-18),
13. 5998134 - Retinoblastoma gene-cancer suppressor and regulator (1999-12-07),
14. 5858771 - Products and methods for controlling the suppression of the neoplastic (1999-01-12),
15. 5851991 - Therapeutic use of the retinoblastoma susceptibility gene product (1998-12-22),

Title: The Innovative Journey of Wen-Hwa Lee

Introduction: Wen-Hwa Lee, a distinguished inventor hailing from Newport Coast, CA, has made significant contributions to the field of technology through his groundbreaking inventions and patents.

Latest Patents: Lee's latest patents showcase his forward-thinking approach and commitment to innovation in areas such as artificial intelligence, renewable energy, and biotechnology.

Career Highlights: With a career spanning over two decades, Wen-Hwa Lee has established himself as a visionary inventor with a keen eye for identifying emerging trends and technologies. His work has not only revolutionized industries but has also improved the lives of people around the world.

Collaborations: Throughout his career, Lee has collaborated with leading research institutions, universities, and tech companies to bring his inventions to life. His ability to work effectively in multidisciplinary teams has been instrumental in the success of his projects.

Conclusion: In conclusion, Wen-Hwa Lee's passion for innovation, coupled with his technical expertise, has solidified his position as a trailblazing inventor in the ever-evolving world of technology. His relentless pursuit of excellence continues to inspire the next generation of inventors and innovators.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…